Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer.

While Src phosphorylation was quantitatively increased after oxaliplatin, the increase did not reach statistical significance ( P = 0.13, Figure 3 ).

also in 111,027 other papers

There was no increase in pSrc after oxaliplatin, although there was a nonsignificant trend toward increased total Src after oxaliplatin chemotherapy.

also in 5,406 other papers